Amanote Research
Register
Sign In
A Developed STING Agonist Has Systemic Antitumor Activity
Cancer Discovery
- United States
doi 10.1158/2159-8290.cd-rw2018-201
Full Text
Open PDF
Abstract
Available in
full text
Categories
Oncology
Date
November 16, 2018
Authors
Unknown
Publisher
American Association for Cancer Research (AACR)
Related search
Recombinant BCG Overexpressing a STING Agonist Elicits Trained Immunity and Improved Antitumor Efficacy in Non-Muscle Invasive Bladder
Larotrectinib Has Antitumor Activity in TRK + Pediatric Solid Tumors
Cancer Discovery
Oncology
Local Delivery of IFNα Has Antitumor Activity in Bladder Cancer
Cancer Discovery
Oncology
GPRC5D CAR T-Cell Therapy Has Antitumor Activity in Multiple Myeloma
Cancer Discovery
Oncology
Chimeric Form of Tumor Necrosis Factor-Α Has Enhanced Surface Expression and Antitumor Activity
Cancer Gene Therapy
Cancer Research
Molecular Medicine
Molecular Biology
Tetrocarcins, New Antitumor Antibiotics. 3. Antitumor Activity of Tetrocarcin A.
Journal of Antibiotics
Drug Discovery
Pharmacology
Risk Factors and Indicators of Severe Systemic Insect Sting Reactions
Allergy: European Journal of Allergy and Clinical Immunology
Allergy
Immunology
GC1118, a Novel Anti-Egfr Antibody, Has Potent KRAS Mutation-Independent Antitumor Activity Compared With Cetuximab in Gastric Cancer
Gastric Cancer
Cancer Research
Medicine
Oncology
Gastroenterology
A Novel Chalcone Derivative Has Antitumor Activity in Melanoma by Inducing DNA Damage Through the Upregulation of ROS Products
Cancer Cell International
Cancer Research
Oncology
Genetics